Patents by Inventor Chaim Aschkenasy

Chaim Aschkenasy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11865208
    Abstract: Topical vaginal compositions are disclosed herein which include silica microspheres and an active ingredient in the amount of 0.001 to 15.0% w/w selected from estradiol, metronidazole, clindamycin, butoconazole, and combinations thereof. The topical compositions provide sustained release of the active ingredient so as to reduce skin irritation.
    Type: Grant
    Filed: September 17, 2020
    Date of Patent: January 9, 2024
    Assignee: Sol-Gel Technologies Ltd.
    Inventors: Marina Shevachman, Amira Ze' Evi, Eilon Asculai, Batella Benyaminovich, Nir Avram, Chaim Aschkenasy
  • Publication number: 20210000741
    Abstract: Topical vaginal compositions are disclosed herein which include silica microspheres and an active ingredient in the amount of 0.001 to 15.0% w/w selected from estradiol, metronidazole, clindamycin, butoconazole, and combinations thereof. The topical compositions provide sustained release of the active ingredient so as to reduce skin irritation.
    Type: Application
    Filed: September 17, 2020
    Publication date: January 7, 2021
    Inventors: MARINA SHEVACHMAN, AMIRA ZE' EVI, EILON ASCULAI, BATELLA BENYAMINOVICH, NIR AVRAM, CHAIM ASCHKENASY
  • Patent number: 10780046
    Abstract: Topical vaginal compositions are disclosed herein which include silica microspheres and an active ingredient in the amount of 0.001 to 15.0% w/w selected from estradiol, metronidazole, clindamycin, butoconazole, and combinations thereof. The topical compositions provide sustained release of the active ingredient so as to reduce skin irritation.
    Type: Grant
    Filed: April 17, 2019
    Date of Patent: September 22, 2020
    Assignee: SOL-GEL TECHNOLOGIES LTD.
    Inventors: Marina Shevachman, Amira Ze'Evi, Eilon Asculai, Batella Binyaminovich, Nir Avram, Chaim Aschkenasy
  • Publication number: 20190240149
    Abstract: Topical vaginal compositions are disclosed herein which include silica microspheres and an active ingredient in the amount of 0.001 to 15.0% w/w selected from estradiol, metronidazole, clindamycin, butoconazole, and combinations thereof. The topical compositions provide sustained release of the active ingredient so as to reduce skin irritation.
    Type: Application
    Filed: April 17, 2019
    Publication date: August 8, 2019
    Inventors: Marina Shevachman, Amira Ze' Evi, Eilon Asculai, Batella Binyaminovich, Nir Avram, Chaim Aschkenasy
  • Patent number: 10278917
    Abstract: Topical vaginal compositions are disclosed herein which include silica microspheres and an active ingredient in the amount of 0.001 to 15.0% w/w selected from estradiol, metronidazole, clindamycin, butoconazole, and combinations thereof. The topical compositions provide sustained release of the active ingredient so as to reduce skin irritation.
    Type: Grant
    Filed: September 22, 2016
    Date of Patent: May 7, 2019
    Assignee: PERRIGO ISRAEL PHARMACEUTICALS LTD.
    Inventors: Marina Shevachman, Amira Ze' Evi, Eilon Asculai, Batella Binyaminovich, Nir Avram, Chaim Aschkenasy
  • Publication number: 20170007539
    Abstract: Topical vaginal compositions are disclosed herein which include silica microspheres and an active ingredient in the amount of 0.001 to 15.0% w/w selected from estradiol, metronidazole, clindamycin, butoconazole, and combinations thereof. The topical compositions provide sustained release of the active ingredient so as to reduce skin irritation.
    Type: Application
    Filed: September 22, 2016
    Publication date: January 12, 2017
    Inventors: Marina Shevachman, Amira Ze' Evi, Eilon Asculai, Batella Binyaminovich, Nir Avram, Chaim Aschkenasy
  • Publication number: 20050042268
    Abstract: A pharmaceutical composition for transdermal administration of a hormone (e.g., testosterone), which includes urea and/or a derivative thereof as a penetration enhancer, and methods utilizing same for treating medical conditions in which elevating a hormone serum level is beneficial are disclosed.
    Type: Application
    Filed: July 15, 2004
    Publication date: February 24, 2005
    Inventors: Chaim Aschkenasy, Oren Chen, Rami Boochnik, Eilon Asculai, Chalil Abu-Gnim, Amira Zeevi
  • Publication number: 20050025833
    Abstract: A pharmaceutical composition for transdermal administration of a hormone (e.g., testosterone), which includes a quaternary ammonium compound as a penetration enhancer, and methods utilizing same for treating medical conditions in which elevating a hormone serum level is beneficial are disclosed.
    Type: Application
    Filed: July 15, 2004
    Publication date: February 3, 2005
    Inventors: Chaim Aschkenasy, Oren Chen, Rami Boochnik, Eilon Asculai, Chalil Abu-Gnim, Amira Zeevi
  • Publication number: 20050020552
    Abstract: A pharmaceutical composition for transdermal administration of a hormone (e.g., testosterone), which includes isostearic acid as a penetration enhancer, and methods utilizing same for treating medical conditions in which elevating a hormone serum level is beneficial are disclosed.
    Type: Application
    Filed: July 15, 2004
    Publication date: January 27, 2005
    Inventors: Chaim Aschkenasy, Oren Chen, Rami Boochnik, Eilon Asculai, Chalil Abu-Gnim, Amira Zeevi